These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6145173)

  • 21. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia.
    Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia in the elderly.
    Antai-Otong D
    Adv Nurse Pract; 2000 Mar; 8(3):38-40, 46. PubMed ID: 11107347
    [No Abstract]   [Full Text] [Related]  

  • 23. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW; Lee JG; Lee BJ; Kim YH
    Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic schizophrenia. Options for pharmacologic management.
    Pary R; Tobias CR; Lippmann S
    Postgrad Med; 1995 Nov; 98(5):163-4, 167-70, 173. PubMed ID: 7479452
    [No Abstract]   [Full Text] [Related]  

  • 25. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
    Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
    Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early hospital experience with fluphenazine decanoate.
    Small JG; Kellams J
    Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics].
    Youssef HA
    Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):297-304. PubMed ID: 6152573
    [No Abstract]   [Full Text] [Related]  

  • 29. Quetiapine for elderly non-responsive schizophrenia patients.
    Mazeh D; Paleacu D; Barak Y
    Psychiatry Res; 2008 Jan; 157(1-3):265-7. PubMed ID: 17928067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic schizophrenia.
    Morgan R
    Br J Hosp Med; 1985 Oct; 34(4):202-5. PubMed ID: 2868767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cholesterol and treatment-resistance in schizophrenia.
    Boston PF; Dursun SM; Zafar R; Reveley MA
    Biol Psychiatry; 1996 Sep; 40(6):542-3. PubMed ID: 8879475
    [No Abstract]   [Full Text] [Related]  

  • 32. NIMH funds study of drugs for schizophrenia and Alzheimer's.
    J Psychosoc Nurs Ment Health Serv; 1999 Dec; 37(12):7. PubMed ID: 10618770
    [No Abstract]   [Full Text] [Related]  

  • 33. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
    Araki T; Yamasue H; Sumiyoshi T; Kuwabara H; Suga M; Iwanami A; Kato N; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An attempt to discontinue long-term psychopharmacologic therapy in chronic schizophrenics].
    Klik J; Fait V; Bat'ková Z
    Cesk Psychiatr; 1984 Apr; 80(2):121-4. PubMed ID: 6147204
    [No Abstract]   [Full Text] [Related]  

  • 35. [Zetidoline in the treatment of schizophrenia--initial experiences].
    Molcan J; Korínková V; Koníková M; Rakús A; Pribyl R
    Cesk Psychiatr; 1984 Jun; 80(3):143-5. PubMed ID: 6148151
    [No Abstract]   [Full Text] [Related]  

  • 36. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 37. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis.
    Lieberman JA
    J Clin Psychiatry; 1996; 57 Suppl 11():68-71. PubMed ID: 8941173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary study of schizophrenics with brain atrophy treated with antipsychotic drugs].
    Wang XY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):294-6, 319. PubMed ID: 2906857
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evaluation of ceruletide in schizophrenia: a multi-institutional cooperative double-blind controlled study.
    Itoh H; Shimazono Y; Kawakita Y; Kudo Y; Satoh Y; Takahashi R
    Psychopharmacol Bull; 1986; 22(1):123-8. PubMed ID: 3523572
    [No Abstract]   [Full Text] [Related]  

  • 40. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M; Laforge E; Muyard J; Blayac J; Lemoine J
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.